Ovation Pharmaceuticals

From Wikipedia, the free encyclopedia
  (Redirected from Ovation Pharma)
Jump to: navigation, search

Ovation Pharmaceuticals, founded in 2000 by Jeffrey Aronin, is a manufacturer of pharmaceuticals products including the popular-selling ADHD medicine Desoxyn, brand name for methamphetamine hydrochloride, and Vigabatrin which is an anticonvulsant that inhibits the catabolism of GABA and is indicated for epilepsy and substance abuse.

Ovation is a privately held corporation based on a business model of acquiring mature but under-promoted pharmaceuticals, as well as pharmaceutical candidates which are far along the development and FDA certification processes. The headquarters of Ovation Pharma is located in Deerfield, Illinois. A major office is also located near Lebanon, New Jersey.

In 2003, Sanofi sold its interests in stanozolol, Methylphenobarbital, and Dimercaptosuccinic acid to Ovation.[1]

In March 2009, the private equity firm GTCR, Ovation, and Lundbeck, announced the Lundbeck had purchased Ovation for $600 million in cash, with further payments of up to $300 million based on regulatory approvals for vigabatrin, an epilepsy drug that was under development at the time.[2]


External links[edit]